| 1 Proportion of participants with low back pain/discomfort follow‐up short‐term |
3 |
107 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.93 [0.69, 1.27] |
| 2 Proportion of participants with upper back pain/discomfort follow‐up short‐term |
2 |
40 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.88 [0.40, 1.96] |
| 3 Proportion of participants with neck pain/discomfort follow‐up short‐term |
3 |
115 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.0 [0.76, 1.32] |
| 4 Proportion of participants with shoulder pain/discomfort follow‐up short‐term |
2 |
66 |
Risk Ratio (Random, 95% CI) |
0.83 [0.12, 5.80] |
| 5 Proportion of participants with wrist/hand pain/discomfort follow‐up short‐term |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 6 Proportion of participants with elbow pain/discomfort follow‐up short‐term |
2 |
20 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.31 [0.09, 1.06] |
| 7 Proportion of participants with hip pain/discomfort follow‐up short‐term |
2 |
34 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.15 [0.56, 2.34] |
| 8 Proportion of participants with knee pain/discomfort follow‐up short‐term |
2 |
43 |
Risk Ratio (M‐H, Random, 95% CI) |
1.25 [0.28, 5.68] |
| 9 Proportion of participants with legs/feet/ankles pain/discomfort follow‐up short‐term |
2 |
37 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.62 [0.34, 1.15] |
| 10 Proportion of participants with extremity pain/discomfort follow‐up short‐term |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 11 Mean difference in low back pain/discomfort follow‐up medium‐term |
1 |
|
Mean Difference (Fixed, 95% CI) |
Totals not selected |
| 12 Mean difference in upper back pain/discomfort follow‐up medium‐term |
1 |
|
Mean Difference (Fixed, 95% CI) |
Totals not selected |
| 13 Mean difference in leg pain/discomfort follow‐up medium‐term |
1 |
|
Mean Difference (Fixed, 95% CI) |
Totals not selected |
| 14 Mean difference in disability follow‐up medium‐term |
1 |
|
Mean Difference (Fixed, 95% CI) |
Totals not selected |
| 15 Proportion of participants with low back pain/discomfort follow‐up long‐term |
2 |
67 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.89 [0.57, 1.40] |
| 16 Proportion of participants with upper back pain/discomfort follow‐up long‐term |
2 |
40 |
Risk Ratio (M‐H, Random, 95% CI) |
0.52 [0.08, 3.29] |
| 17 Proportion of participants with neck pain/discomfort follow‐up long‐term |
2 |
60 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.67 [0.41, 1.08] |
| 18 Proportion of participants with shoulder pain/discomfort follow‐up long‐term |
2 |
66 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.93 [0.57, 1.54] |
| 19 Proportion of participants with wrist/hand pain/discomfort follow‐up long‐term |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 20 Proportion of participants with legs/feet/ankle pain/discomfort follow‐up long‐term |
2 |
37 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.48 [0.74, 2.96] |
| 21 Proportion of participants with hip pain/discomfort follow up long‐term |
2 |
34 |
Risk Ratio (M‐H, Random, 95% CI) |
0.92 [0.36, 2.37] |
| 22 Proportion of participants with knee pain/discomfort follow‐up long‐term |
2 |
43 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.91 [0.46, 1.79] |
| 23 Proportion of participants elbow pain/discomfort follow‐up long‐term |
2 |
20 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.35 [0.08, 1.52] |
| 24 Proportion of participants with low back pain follow‐up short‐term (CBA) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 25 Proportion of participants with upper back pain follow‐up short‐term (CBA) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 26 Proportion of participants with neck pain follow‐up short‐term (CBA) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 27 Proportion of participants with shoulder pain follow‐up short‐term (CBA) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 28 Proportion of participants with elbow pain follow‐up short‐term (CBA) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 29 Proportion of participants with wrist/hand pain follow‐up short‐term (CBA) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 30 Proportion of participants with legs/feet/ankles pain follow‐up short‐term (CBA) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 31 Proportion of participants with hip pain follow‐up short‐term (CBA) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 32 Proportion of participants with knee pain follow‐up short‐term (CBA) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
